MWNA
CMAX

Marshall Wace North America’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

Marshall Wace North America’s Portfolio CMAX Stock Details CMAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$210K Buy
+722
New +$212K ﹤0.01% 1311

Other funds holding CMAX

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACM
Alua Capital Management New York $103M AUM 11.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace North America's CMAX Position: Q3 2021 in Review

Marshall Wace North America opened a new position in CareMax, Inc. Class A Common Stock (CMAX) in Q3 2021: 722 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #1311 among its holdings.

53 funds tracked by Wall St. Rank hold CMAX as of Q3 2021.

  • Marshall Wace North America held 722 shares of CareMax, Inc. Class A Common Stock worth $210K as of Q3 2021.
  • CareMax, Inc. Class A Common Stock was a new Marshall Wace North America position in Q3 2021.
  • CareMax, Inc. Class A Common Stock made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1311 holding.
  • 53 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.